Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEGeneral UpdatesResults29 Jul 2026

V-Guard Industries Limited

General Updates

V-Guard Industries Limited has informed the Exchange about General Updates. The Board of Directors have approved the Un-Audited Standalone & Consolidated Financial Results of the Company for the quarter ended June 30, 2026. The Un-Audited Financial Results and Limited Review Report thereon as submitted by the Auditors of the Company are enclosed herewith. The Board has also allotted 23,912 nos. of equity shares having face value of ₹ 1/- each to six (6) employees who have exercised stock options under Employee Stock Option Scheme of the Company 'ESOS 2013'. The second and final term of Ms. Radha Unni, Chairperson and Independent Director will conclude on September 26, 2026. Accordingly, the Board has approved the appointment of Mr. Mithun K Chittilappilly as Chairperson of the Board w.e.f. September 27, 2026.

Read more →📎 1 attachment
NSEInvestor PresentationResults29 Jul 2026

KPIT Technologies Limited

Investor Presentation

KPIT Technologies Limited has released its Q1 FY 2026-27 results, showing a 0.1% YoY CC revenue growth, a 0.6% YoY revenue decline, and a QoQ CC revenue decline of 3.6%. The company reported an EBITDA of 17.2% and an EBIT of 12.3% for Q1FY27. Net cash stood at ₹ 9.0 Bn as at quarter end, and DSO stood at 51 days.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults29 Jul 2026

Sukhjit Starch & Chemicals Limited

Press Release

Sukhjit Starch & Chemicals Ltd has announced its unaudited financial results for Q1 FY27, reporting a 7.60% YoY revenue growth, with revenue from operations increasing to ₹395.12cr from ₹367.20cr in Q1 FY26.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults29 Jul 2026

Vinati Organics Limited

Outcome of Board Meeting

Vinati Organics Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and the Statutory Auditors carrying out a Limited Review.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults29 Jul 2026

V-Guard Industries Limited

Outcome of Board Meeting

V-Guard Industries Limited has announced its unaudited standalone financial results for the quarter ended June 30, 2026, with revenue from operations at ₹1,736.87 crore and profit before tax at ₹143.72 crore. The company has also approved the allotment of 23,912 equity shares to six employees under the Employee Stock Option Scheme and appointed Mr. Mithun K Chittilappilly as the new Chairperson of the Board.

Read more →📎 1 attachment
NSEAllotment of SecuritiesResults29 Jul 2026

V-Guard Industries Limited

Allotment of Securities

V-Guard Industries Limited has informed the Exchange regarding allotment of 23,912 securities pursuant to ESOP/ESPS and approval of Un-Audited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026. The Board of Directors has also approved the appointment of Mr. Mithun K Chittilappilly as Chairperson of the Board w.e.f. September 27, 2026.

Read more →📎 1 attachment
NSEUpdatesResults29 Jul 2026

Vidhi Specialty Food Ingredients Limited

Updates

Vidhi Specialty Food Ingredients Limited has informed the Exchange regarding 'outcome of Board Meeting ' where the company considered and approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, and convened the 33rd Annual General Meeting of the Company on Wednesday, September 24, 2026.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults29 Jul 2026

Meghmani Organics Limited

Outcome of Board Meeting

Meghmani Organics Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, with a net profit of Rs. 5,759.90 lakhs. The company has also appointed Mr. Naresh Prajapati as the Company Secretary and Compliance Officer.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults29 Jul 2026

Meghmani Organics Limited

Outcome of Board Meeting

Meghmani Organics Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 52,294.32 lakhs and net profit at Rs. 5,759.90 lakhs. The company has also appointed Mr. Naresh Prajapati as its Company Secretary and Compliance Officer.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults29 Jul 2026

Mangalam Organics Limited

Copy of Newspaper Publication

Mangalam Organics Limited has informed the Exchange about the publication of a newspaper advertisement regarding the extract of the Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults29 Jul 2026

Eris Lifesciences Limited

Investor Presentation

Eris Lifesciences Limited has released its Q1 FY27 financial highlights, showing a 14.2% YoY revenue growth and 14.5% YoY consolidated PAT growth. The company's Domestic Branded Formulations (DBF) segment reported a 14.2% organic growth, with 7 out of 10 therapies in its portfolio clocking double-digit growth rates. The company has established an early leadership in the GLP-1 (Semaglutide) market and has a strong pipeline of 5 insulin products set to launch starting FY28.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults29 Jul 2026

SKM Egg Products Export (India) Limited

Outcome of Board Meeting

SKM Egg Products Export (India) Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 18,684 lakhs, operating profit at Rs. 4,794 lakhs, and profit before tax at Rs. 4,125 lakhs. The company has also recommended a final dividend of Rs. 1.25 per equity share.

Read more →📎 1 attachment
NSEOptions to purchase securitiesResults29 Jul 2026

Devyani International Limited

Options to purchase securities

Devyani International Limited has informed the Exchange about the grant of 27,13,700 stock options under the Employees Stock Option Scheme 2021 (‘ESOP 2021’) to eligible employees. The options are exercisable within a period of 5 years from the date of vesting and are convertible into one fully paid-up equity share of the Company having a face value of Re. 1/- each.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults29 Jul 2026

Eris Lifesciences Limited

Outcome of Board Meeting

Eris Lifesciences Limited has submitted its financial results for the period ended June 30, 2026, and has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults29 Jul 2026

RPG Life Sciences Limited

Copy of Newspaper Publication

RPG Life Sciences Limited has published unaudited financial results for the quarter ended June 30, 2026, in accordance with SEBI regulations. The results are available on the company's website and in newspapers.

Read more →📎 1 attachment
← PreviousPage 1310 of 1580Next →